ENGAGE THERAPEUTICS, INC.

Profile

Company Names

ENGAGE THERAPEUTICS, INC.

Addresses

31 LENOX ROAD, SUMMIT, NJ 07901

Phone Numbers

215-696-9659

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2016

State Incorporated:

DELAWARE

Total Amount Raised:

$30,599,999.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2019-10-18 
$6,999,999.00 
$12,000,000.00 
$5,000,001.00 
Debt 
1
2017-09-26 
$23,600,000.00 
$23,600,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GERRY 
 
BRUNK 
DIRECTOR
CARDIAC DIMENSIONS INC   |  DC DEVICES, INC.   |  CELTAXSYS, INC.   |  CORVIA MEDICAL, INC.   |  ENDOTRONIX INC   |  ENGAGE THERAPEUTICS, INC.   |  HISTOSONICS, INC.   |  CYRANO THERAPEUTICS, INC.   |  PIC THERAPEUTICS, INC.   |  CADENCE NEUROSCIENCE, INC.   |  GENEP, INC.   |  SPECTRAWAVE, INC.
STEPHEN 
 
COLLINS 
DIRECTOR
MOONTOAST, LLC   |  MOONTOAST, INC.   |  CANTOR REAL ESTATE INCOME + OPPORTUNITY FUND, LLC   |  SPINIFEX PHARMACEUTICALS INC   |  XALUD THERAPEUTICS, INC.   |  MEDIASPECTRUM, INC.   |  WHEAT SELF-STORAGE PARTNERS I, LP   |  OSKA, INC.   |  ENGAGE THERAPEUTICS, INC.   |  PGIM SENIOR LOAN OPPORTUNITIES (LEVERED) I, L.P.   |  PGIM SENIOR LOAN OPPORTUNITIES I CO-INVESTMENT II (FEEDER FUND), LP   |  PGIM SENIOR LOAN OPPORTUNITIES I CO-INVESTMENT II, LP   |  ATOMBEAM TECHNOLOGIES INC.   |  PGIM SENIOR LOAN OPPORTUNITIES (PARALLEL FUND) II, L.P.   |  PGIM SENIOR LOAN OPPORTUNITIES (LEVERED) II, L.P.   |  PGIM SENIOR LOAN OPPORTUNITIES (UNLEVERED) II, L.P.   |  PGIM SENIOR LOAN OPPORTUNITIES (RATED FEEDER FUND) II, L.P.   |  PGIM SENIOR LOAN OPPORTUNITIES II JPY FEEDER FUND, L.P.
STEPHEN 
D. 
COLLINS 
DIRECTOR
BISCAYNE PHARMACEUTICALS INC.   |  ENGAGE THERAPEUTICS, INC.
ORRIN 
 
DEVINSKY 
DIRECTOR
ENGAGE THERAPEUTICS, INC.   |  SILVER SPIKE ACQUISITION CORP.   |  SOMNUM PHARMA, INC.   |  PHIFUND2, LP
JOUKO 
 
ISOJARVI 
EXECUTIVE OFFICER
ENGAGE THERAPEUTICS, INC.
WARREN 
 
LAMMERT 
DIRECTOR
BISCAYNE PHARMACEUTICALS INC.   |  ENGAGE THERAPEUTICS, INC.   |  CEREBRAL THERAPEUTICS, INC.   |  RECEPTOR HOLDINGS, INC.
HEATH 
 
LUKATCH 
DIRECTOR
INOGEN INC   |  ANAPTYSBIO INC   |  CIANNA MEDICAL INC   |  ELEVATION PHARMACEUTICALS INC   |  FLEXION THERAPEUTICS INC   |  SPINIFEX PHARMACEUTICALS INC   |  SATSUMA PHARMACEUTICALS, INC.   |  ADYNXX, INC.   |  ENGAGE THERAPEUTICS, INC.   |  VIEWPOINT THERAPEUTICS, INC.   |  HALO NEURO INC.   |  SUTROVAX, INC.   |  VIACYTE INC.   |  CARGO THERAPEUTICS, INC.   |  MAGNUS MEDICAL, INC.
GREGORY 
 
MAYES 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
UNIGENE LABORATORIES INC   |  ENGAGE THERAPEUTICS, INC.   |  ANTIOS THERAPEUTICS INC.   |  RECEPTOR HOLDINGS, INC.   |  REUNION NEUROSCIENCE MANAGEMENT, INC.   |  REUNION NEUROSCIENCE, INC.
MARK 
 
THEEUWES 
EXECUTIVE OFFICER
ENGAGE THERAPEUTICS, INC.   |  RECEPTOR HOLDINGS, INC.   |  REUNION NEUROSCIENCE MANAGEMENT, INC.   |  REUNION NEUROSCIENCE, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-10-29
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2019-10-18 
2017-10-10
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-09-26 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
LIFESCI CAPITAL LLC
168404